At Telara Pharma, we develop innovative therapies based on cilastatin, a drug with a solid safety record and a powerful neuroprotective effect on the retina. Our goal is to transform glaucoma and diabetic retinopathy retreatments through a strategy that targets retinal neurodegeneration and inflammation—two key processes that current medicine does not address. Unlike therapies focused solely on reducing intraocular pressure (IOP), our ophthalmic drops directly protect retinal ganglion cells, preserving vision and quality of life.

Telara Pharma

Org chart

Teams

Offices

Telara Pharma

Org chart

Teams

Offices

Related companies